Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial

CL Creutzberg, WLJ van Putten, PCM Koper… - The Lancet, 2000 - thelancet.com
Summary Background Postoperative radiotherapy for International Federation of
Gynaecology and Obstetrics (FIGO) stage-1 endometrial carcinoma is a subject of …

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

R Pötter, K Tanderup, MP Schmid… - The Lancet …, 2021 - thelancet.com
Background The concept of the use of MRI for image-guided adaptive brachytherapy
(IGABT) in locally advanced cervical cancer was introduced 20 years ago. Here, we report …

[HTML][HTML] Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label …

SM de Boer, ME Powell, L Mileshkin, D Katsaros… - The lancet …, 2018 - thelancet.com
Background Although women with endometrial cancer generally have a favourable
prognosis, those with high-risk disease features are at increased risk of recurrence. The …

Survival after relapse in patients with endometrial cancer: results from a randomized trial☆

CL Creutzberg, WLJ van Putten, PC Koper… - Gynecologic …, 2003 - Elsevier
OBJECTIVE: The aim of this study was to determine the rates of local control and survival
after relapse in patients with stage I endometrial cancer treated in the multicenter …

[HTML][HTML] Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma

CL Creutzberg, RA Nout, MLM Lybeert… - International Journal of …, 2011 - Elsevier
PURPOSE: To evaluate the very long-term results of the randomized Post Operative
Radiation Therapy in Endometrial Carcinoma (PORTEC)-1 trial for patients with Stage I …

[HTML][HTML] Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer–a pooled analysis of PORTEC 1 and 2 trials

T Bosse, EEM Peters, CL Creutzberg… - European journal of …, 2015 - Elsevier
Background Lymph-vascular space invasion (LVSI) is an important adverse prognostic
factor in endometrial cancer (EC). However, its role in relation to type of recurrence and …

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial

RA Nout, H Putter, IM Jürgenliemk-Schulz… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Studies on quality of life (QOL) among women with endometrial cancer have shown
that patients who undergo pelvic radiotherapy report lower role functioning and more …

[PDF][PDF] Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma …

CL Creutzberg, WLJ van Putten… - Journal of Clinical …, 2004 - researchgate.net
Purpose Stage IC, grade 3 endometrial cancer is regarded as a high-risk category. Stage IC,
grade 3 patients were not eligible for the randomized Postoperative Radiation Therapy in …

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review

AN Scholten, WLJ van Putten, H Beerman… - International Journal of …, 2005 - Elsevier
Purpose: In 2000, the results of the multicenter Post Operative Radiation Therapy in
Endometrial Carcinoma (PORTEC) trial were published. This trial included 714 Stage I …

Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in …

RA Nout, LV van de Poll-Franse… - Journal of Clinical …, 2011 - ascopubs.org
Purpose To determine the long-term outcome and health-related quality of life (HRQL) of
patients with endometrial carcinoma (EC) treated with or without pelvic radiotherapy in the …